Improved retroviral vectors for gene transfer and expression
- PMID: 2631796
- PMCID: PMC1360503
Improved retroviral vectors for gene transfer and expression
Abstract
We describe a set of murine retrovirus-based vectors that include unique cloning sites for insertion of cDNAs such that the cDNA can be driven by either the retroviral long terminal repeat, the immediate early promoter of human cytomegalovirus, or the simian virus 40 early promoter. The vectors carry the neomycin phosphotransferase gene expressed from an alternate promoter as a selectable marker. These vectors have been constructed to prevent viral protein synthesis from the remaining viral sequences, to yield high-titer virus stocks after introduction into retrovirus packaging cells, and to eliminate homologous overlap with viral DNAs present in retrovirus packaging cells in order to prevent helper virus production. Methods for generating high-titer virus are described.
Figures
Similar articles
-
Production of retroviral vectors.Curr Protoc Hum Genet. 2001 May;Chapter 12:Unit 12.5. doi: 10.1002/0471142905.hg1205s11. Curr Protoc Hum Genet. 2001. PMID: 18428250
-
A convenient method for positive selection of retroviral producing cells generating vectors devoid of selectable markers.J Virol Methods. 2004 Jun 1;118(1):61-7. doi: 10.1016/j.jviromet.2004.01.024. J Virol Methods. 2004. PMID: 15158069
-
An improved method for generating retroviral producer clones for vectors lacking a selectable marker gene.Blood Cells Mol Dis. 1998 Jun;24(2):167-82. doi: 10.1006/bcmd.1998.0184. Blood Cells Mol Dis. 1998. PMID: 9642098
-
Retrovirus packaging cells.Hum Gene Ther. 1990 Spring;1(1):5-14. doi: 10.1089/hum.1990.1.1-5. Hum Gene Ther. 1990. PMID: 2081186 Review.
-
Recent advances in retrovirus vector technology.Curr Opin Genet Dev. 1993 Feb;3(1):102-9. doi: 10.1016/s0959-437x(05)80349-1. Curr Opin Genet Dev. 1993. PMID: 8453267 Review.
Cited by
-
Hematopoietic colony formation from human growth factor-dependent TF1 cells and human cord blood myeloid progenitor cells depends on SHP2 phosphatase function.Stem Cells Dev. 2013 Mar 15;22(6):998-1006. doi: 10.1089/scd.2012.0478. Epub 2012 Dec 16. Stem Cells Dev. 2013. PMID: 23082805 Free PMC article.
-
Oncogenic fusion protein FGFR2-PPHLN1: Requirements for biological activation, and efficacy of inhibitors.Transl Oncol. 2020 Dec;13(12):100853. doi: 10.1016/j.tranon.2020.100853. Epub 2020 Aug 24. Transl Oncol. 2020. PMID: 32854034 Free PMC article.
-
Selection of recombinant MVA by rescue of the essential D4R gene.Virol J. 2011 Dec 12;8:529. doi: 10.1186/1743-422X-8-529. Virol J. 2011. PMID: 22152060 Free PMC article.
-
Modulation of the cellular distribution of human cytomegalovirus helicase by cellular factor Snapin.J Virol. 2013 Oct;87(19):10628-40. doi: 10.1128/JVI.01657-13. Epub 2013 Jul 24. J Virol. 2013. PMID: 23885069 Free PMC article.
-
Human gene therapy: present and future.Breast Cancer Res Treat. 1992;21(2):83-93. doi: 10.1007/BF01836954. Breast Cancer Res Treat. 1992. PMID: 1627818 Review.
References
-
- Beck E, Ludwig G, Auerswald EA, Reiss B, Schaller H. Nucleotide sequence and exact localization of the neomycin phosphotransferase gene from transposon Tn5. Gene. 1982;19:327–336. - PubMed
-
- Boshart M, Weber F, Jahn G, Dorsch-Hsler K, Fleckenstein B, Schaffner W. A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell. 1985;41:521–530. - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources